Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Risk | NA | High |
Rating | 3.0 | 4.0 |
Min SIP Amount | ₹250 | ₹100 |
Expense Ratio | 2 | 1.72 |
NAV | ₹45.36 | ₹77.43 |
Fund Started | 09 Aug 2004 | 16 Feb 2004 |
Fund Size | ₹812.15 Cr | ₹3264.25 Cr |
Exit Load | Exit load of 1% if redeemed within 6 months | Exit load for units in excess of 30% of the investment,1% will be charged for redemption within 1 year |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 5.80% | 7.97% |
3 Year | 8.49% | 10.26% |
5 Year | 7.74% | 9.92% |
1 Year
3 Year
5 Year
Equity | 23.45% | 22.04% |
Cash | 0.35% | 8.38% |
Equity
Cash
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
HDFC Bank Ltd. | 1.97% |
ICICI Bank Ltd. | 1.33% |
Reliance Industries Ltd. | 1.01% |
Larsen & Toubro Ltd. | 0.68% |
Infosys Ltd. | 0.67% |
Tech Mahindra Ltd. | 0.63% |
Cummins India Ltd. | 0.60% |
Travel Food Services Ltd. | 0.58% |
State Bank of India | 0.56% |
Bajaj Finance Ltd. | 0.55% |
Name | Assets |
|---|---|
ICICI Bank Ltd. | 1.54% |
SBI Life Insurance Company Ltd. | 1.31% |
Maruti Suzuki India Ltd. | 1.02% |
HDFC Life Insurance Co Ltd. | 1.00% |
HDFC Bank Ltd. | 0.99% |
Infosys Ltd. | 0.97% |
NTPC Ltd. | 0.94% |
Hindustan Unilever Ltd. | 0.93% |
Sun Pharmaceutical Industries Ltd. | 0.87% |
Axis Bank Ltd. | 0.87% |
Name | Shreekiran Rao | Ritesh Lunawat |
Start Date | 01 Dec 2022 | 28 Dec 2020 |
Name
Start Date
Description | The scheme aims to generate regular returns through investment primarily in debt and money market instruments. It would also invest a portion of its assets in equity and equity related securities to generate long term appreciation. | The scheme seeks to generate long-term capital appreciation by investments in money market and debt instruments. |
Launch Date | 09 Aug 2004 | 16 Feb 2004 |
Description
Launch Date